Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs USFR✓SelectedUSD · USFRGSK vs USFR performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs USFR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+87.1%
USFR return
+28.6%
Excess return
+58.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioUSFRExcessAlpha
1D+0.5%0.0%+0.5%+0.5%
7D+1.1%+0.1%+1.1%+1.1%
30D+6.3%+0.4%+6.0%+6.3%
3M+1.8%+1.1%+0.8%+1.6%
6M+1.7%+2.0%-0.4%+1.3%
YTD+6.5%+3.5%+3.1%+5.9%
1Y+9.5%+4.1%+5.4%+8.7%
3Y+65.3%+14.4%+50.9%+61.3%
5Y+43.7%+21.4%+22.3%+38.8%
10Y+104.1%+28.6%+75.6%+95.1%
All+87.1%+28.6%+58.5%+77.2%

Cumulative growth

Daily Returns

Daily percentage return beside USFR.

Daily Out/Under-Performance

Portfolio return minus USFR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × USFR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded USFR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling